Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid Tumors
Clinical trial NCT00045201 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00045201
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-06-13
- Primary completion
- 2013-09-13
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.